Cytotoxity of pomalidomide combined CAR-T cell for multiple myeloma cell RPMI8226 and U266.
- VernacularTitle:泊马度胺联合CAR-T细胞对多发性骨髓瘤细胞株RPMI8226、U266细胞的体外杀伤作用
- Author:
Lei WANG
1
,
2
;
Shuting ZHANG
1
;
Jianfeng OU
1
;
Hai BAI
1
;
Author Information
- Publication Type:Journal Article
- MeSH: Cell Line, Tumor; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Humans; Multiple Myeloma; Recoverin; T-Lymphocytes; Thalidomide; analogs & derivatives
- From: Chinese Journal of Hematology 2015;36(6):497-500
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the cytotoxity of CD138-CAR-T cells on human multiple myeloma cell RPMI8226 and U266 cells and explore the impact of pomalidomide on the cytotoxity of CD138-CAR-T on RPMI8226 and U266 cells.
METHODSThe cytotoxity of CD138-CAR-T and CD138-CAR-T combined pomalidomide on RPMI8226 and U266 was detected by CFSE/7AAD. The effctor cells were co-cultured with target cells at 5:1 for 18 h, and then the supernatant were collected and used for ELISA assays.
RESULTSAfter 18 h co-culture, the cytotoxity of CD138-CAR-T on RPMI8226 and U266 was significantiy higher than control (P<0.01). There was no significant change on the cytotoxity of pomalidoide combined with CD138-CAR-T on RPMI8226 and U266. The results showed that co-cultured system contribted to a markedly increased production of IFN-γ, after adding pomalidomide to the co-cultured system. It can significantly enhance the production of IFN-γ, compared with CD138-CAR-T alone.
CONCLUSIONCD138-CAR-T had significantly cytotoxity on U266 and RPMI8226. Pomalidomide could promote CD138-CAR-T cells IFN-γ production.
